Patrick M. Schlievert
21Patents
5h-index
13Co-inventors
66Inventor score
Filing activity: Apr 5, 1993 → Jan 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6632441B2 | Mutants of streptococcal toxin a and methods of use | Human Necessities | 11 | Expired |
| US5460813A | Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin | Human Necessities | 10 | Expired |
| US9724295B2 | Compositions for topical treatment of microbial infections | Emerging Cross-Sectional Technologies | 5 | Active |
| US6913755B2 | Mutants of Streptococcal toxin A and methods of use | Human Necessities | 5 | Expired |
| US6835818B2 | Mutants of Streptococcal toxin C and methods of use | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6870042B1 | Mutants of streptococcal toxin A and methods of use | Human Necessities | 5 | Expired |
| US8796332B2 | Compositions and methods for controlling infections | Human Necessities | 3 | Active |
| US5470716A | Method for diagnosing kawasaki syndrome | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6774218B2 | Mutants of streptococcal toxin C and methods of use | Human Necessities | 3 | Expired |
| US10342776B2 | Compositions and methods for controlling infections | Human Necessities | 3 | Active |
| US9603824B2 | Compositions and methods for controlling infections | Human Necessities | 3 | Active |
| US5476767A | Isolated nucleic acid molecule coding for toxin associated with Kawasaki Syndrome and uses thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5585465A | Isolated toxin associated with Kawasaki syndrome | Emerging Cross-Sectional Technologies | 2 | Expired |
| US11365176B2 | Antimicrobial and antiviral sulfur containing glycerol monoester derivatives | Emerging Cross-Sectional Technologies | 2 | Active |
| US11572342B2 | Antimicrobial and antiviral sulfur containing glycerol monoester derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US11786454B2 | Compositions for topical treatment of microbial infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US9187529B2 | Cationic peptides and use of such peptides for inhibiting exotoxin production | Emerging Cross-Sectional Technologies | 0 | Active |
| US8569365B2 | Compositions and methods for controlling infections | General | 0 | Revoked |
| US11873272B2 | Antimicrobial and antiviral sulfur containing glycerol monoester derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US9789176B2 | Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus | Chemistry; Metallurgy | 0 | Active |
| US12194140B2 | Compositions for topical treatment of microbial infections | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.